<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for TZYM</title>
    <link />
    <description>Headlines for Tranzyme, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>3 Health Care Stocks Under $10 to Watch</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-health-care-stocks-under-10-watch.html-0.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 09 May 2013 21:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Tranzyme, Ocera Announce Merger Agreement</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3522735/tranzyme-ocera-announce-merger-agreement.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 23 Apr 2013 20:41:02 GMT</pubDate>
    </item>
    <item>
      <title>After-Hours Earnings Report for March 28, 2013 :  PCTI, TZYM, AUXO, ILIU</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/afterhours-earnings-report-for-march-28-2013-pcti-tzym-auxo-iliu-cm231858.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Thu, 28 Mar 2013 14:00:05 GMT</pubDate>
    </item>
    <item>
      <title>3 Micro-Caps With Sustainable Cash Flows</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1178211-3-micro-caps-with-sustainable-cash-flows.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 13 Feb 2013 11:39:08 GMT</pubDate>
    </item>
    <item>
      <title>A Peek Into The Market Before The Trading Starts</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3316971/a-peek-into-the-market-before-the-trading-starts.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 08 Feb 2013 07:23:53 GMT</pubDate>
    </item>
    <item>
      <title>Tranzyme Pharma to Explore Strategic Alternatives</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3316670/tranzyme-pharma-to-explore-strategic-alternatives.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 08 Feb 2013 05:51:45 GMT</pubDate>
    </item>
    <item>
      <title>Speculative Biotech Stocks That Could Bounce</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1165701-speculative-biotech-stocks-that-could-bounce.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 07 Feb 2013 15:57:32 GMT</pubDate>
    </item>
    <item>
      <title>Tranzyme Pharma Names David Moore Chief Business Officer</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3243009/tranzyme-pharma-names-david-moore-chief-business-officer.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 15 Jan 2013 06:10:14 GMT</pubDate>
    </item>
    <item>
      <title>Is Tranzyme A Takeover Target For Bristol-Myers Squibb?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1110071-is-tranzyme-a-takeover-target-for-bristol-myers-squibb.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 14 Jan 2013 09:37:14 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging News for Tranzyme Pharma - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/89884/encouraging-news-for-tranzyme-pharma.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 07 Jan 2013 17:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Tranzyme Completes Drug Discovery Collaboration With Bristol-Myers Squibb</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3214732/tranzyme-completes-drug-discovery-collaboration-with-bristol-myers-squibb.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 04 Jan 2013 06:05:48 GMT</pubDate>
    </item>
    <item>
      <title>Mixed Trial Results from Omeros   - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/89566/mixed-trial-results-from-omeros.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 02 Jan 2013 18:05:01 GMT</pubDate>
    </item>
    <item>
      <title>Tranzyme Announces DIGEST Trial Stopped After Insufficient Efficacy from Phase 2b Results</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/12/12/3177952/tranzyme-announces-digest-trial-stopped-after-insufficient-efficacy-from-phase-2b.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 17 Dec 2012 08:02:22 GMT</pubDate>
    </item>
    <item>
      <title>Is There An Opportunity With Tranzyme After Stock Falls Over 75%?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1022761-is-there-an-opportunity-with-tranzyme-after-stock-falls-over-75.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 21 Nov 2012 06:56:13 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech: Part 2</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/17/this-week-in-biotech-part-2-2/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 17 Nov 2012 12:05:00 GMT</pubDate>
    </item>
    <item>
      <title>The Nasdaq Now: Tranzyme Collapses After Drug Trial Failure</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/business-news/markets/articles/255eixic-nasdaq-now-tranzyme-collapses-after/11/15/2012/id/45880.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Thu, 15 Nov 2012 12:25:00 GMT</pubDate>
    </item>
    <item>
      <title>Massive Meltdown for This Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/15/massive-meltdown-for-this-biotech/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 15 Nov 2012 10:54:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20121115-000412&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Thu, 15 Nov 2012 09:01:59 GMT</pubDate>
    </item>
    <item>
      <title>Tranzyme Stomach Paralysis Drug Comes Up Short</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11768448/1/tranzyme-stomach-paralysis-drug-comes-up-short.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 15 Nov 2012 08:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Tranzyme Investors: Why Shares Just Got Halved</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/03/12/tranzyme-investors-why-shares-just-got-halved/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 12 Mar 2012 19:32:53 GMT</pubDate>
    </item>
  </channel>
</rss>
